Saturday 17 October 2026 Export LXRX’s income statement to Excel — free account

Lexicon Pharmaceuticals, Inc.

Lexicon Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $49.8 million, up 60.2% from fiscal 2024. In the quarter to June 2026, revenue fell 97.6%, EPS fell 800.0%, free cash flow fell 154.1% and total debt fell 8.32%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

1.52 0.13 −7.88%

Follow LXRX

Alert me

Market cap: $734.2M
P/E: 0.0×
Fwd P/E: −12.1×
Dividend yield: —
F-score: 4/9
Altman Z: −12.11
Beneish M: −1.17
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		6.92	8.38	8.97	25.33
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(20.58)	(24.23)	(42.39)	(114.27)
P/B ratio Full definition →		4.08	3.88	3.08	6.02
Price to Tangible BV Full definition →		6.49	6.63	3.94	8.08
EV/Sales Full definition →		6.68	7.54	7.29	22.08
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(6.56)	(5.53)	(13.09)	(14.09)
EV/FCF Full definition →		(6.47)	(5.45)	(12.75)	(13.87)
Quick Ratio Full definition →		5.45	4.73	18.43	13.07
Current Ratio Full definition →		5.64	4.88	18.79	13.37
Net Debt/EBITDA Full definition →		5.11	2.98	590.12	5.37
Debt/Assets Full definition →		27.44%	29.19%	18.48%	20.57%
Debt/Equity Full definition →		0.47	0.50	0.24	0.29
Asset Turnover Full definition →		0.27	0.21	0.25	0.17
Operating CF/Net income Full definition →		1.87	1.11	14.12	0.29
Capex/Depreciation Full definition →		0.00	0.00	0.00	0.00
Interest Coverage Full definition →		(5.66)	(7.28)	(0.63)	(10.17)
Research and Development Expense of Revenue Full definition →		132.26%	205.97%	60.45%	2,520.66%
Selling, General and Administrative Expense of Revenue Full definition →		53.60%	159.46%	43.76%	1,408.96%
Intangible Assets out of Total Assets Full definition →		0.22	0.24	0.17	0.18
Share Based Compensation of Revenue Full definition →		24.28%	51.61%	14.59%	482.08%
Graham Net Nets Full definition →		0.07	0.06	0.19	0.12
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(14.07%)	(12.17%)	(4.65%)	(6.36%)
Free Cash Flow Yield Full definition →		(14.91%)	(16.50%)	(6.38%)	(6.29%)
Revenue per Share Full definition →		0.04	0.02	0.05	0.00
Operating CF per Share Full definition →		(0.07)	(0.05)	(0.04)	(0.02)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.07)	(0.05)	(0.04)	(0.02)
Cash per Share Full definition →		0.32	0.27	0.43	0.44
Shareholders Equity per Share Full definition →		0.33	0.30	0.51	0.40
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.33	0.30	0.51	0.40
Free Cash Flow Full definition →		(23.83)	(17.23)	(14.73)	(9.19)
Working Capital Full definition →		100.81	81.03	176.13	181.87
Net Current Asset Value Full definition →		36.76	24.45	120.07	121.04
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		2.61	2.93	29.61	1.91
Average Payables Full definition →		9.00	8.94	6.84	4.12
Average Inventory Full definition →		0.40	0.26	0.24	0.68
Average Assets Full definition →		263.53	241.70	283.25	237.82
Average Common Equity Full definition →		149.34	126.74	162.94	151.98

Show all line items

Columns are period end dates

Stockrow Weekly